NEW YORK (GenomeWeb) – The Government of Canada announced yesterday the funding of the country's first national cancer research network, pledging C$25 million (US$21.5 million) over five years to quickly translate the most promising laboratory research into cancer therapies. Private sector and non-profit partners, including Genome British Columbia, will contribute an additional C$35 million (US$30.1 million).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.

Sponsored by

In these times of economic constraint and increasing research costs, shared resource cores have become a cost-effective and essential platform for researchers who seek to investigate complex translational research questions.